Viewing Study NCT02217566


Ignite Creation Date: 2025-12-24 @ 4:41 PM
Ignite Modification Date: 2026-02-24 @ 3:13 PM
Study NCT ID: NCT02217566
Status: COMPLETED
Last Update Posted: 2020-01-13
First Post: 2014-08-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy
Sponsor: Janssen Research & Development, LLC
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CR103352
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators